CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 89 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-25 | Gurrola Sandra M SVP of Finance | Shares withheld for taxes | −114 | $1.48 | $169 | 33,695 |
| 2020-03-13 | Wolff Allen CEO | Grant or award | +947 | $1.75 | $2K | 139,578 |
| 2020-02-28 | Wolff Allen CEO | Grant or award | +778 | $2.13 | $2K | 138,631 |
| 2020-02-25 | Gurrola Sandra M SVP of Finance | Shares withheld for taxes | −115 | $2.05 | $236 | 33,809 |
| 2020-02-25 | Wolff Allen CEO | Shares withheld for taxes | −285 | $2.05 | $584 | 137,853 |
| 2020-02-14 | Wolff Allen CEO | Grant or award | +877 | $1.89 | $2K | 138,138 |
| 2020-01-31 | Wolff Allen CEO | Grant or award | +743 | $2.23 | $2K | 137,261 |
| 2020-01-29 | Wolff Allen CEO | Shares withheld for taxes | −285 | $2.43 | $693 | 131,416 |
| 2020-01-29 | Wolff Allen CEO | Grant or award | +5,102 | 136,518 | ||
| 2020-01-29 | Gurrola Sandra M SVP of Finance | Shares withheld for taxes | −114 | $2.43 | $277 | 33,924 |
| 2020-01-19 | Wolff Allen CEO | Grant or award | +75,000 | 131,701 | ||
| 2020-01-19 | Gurrola Sandra M SVP of Finance | Grant or award | +25,000 | 34,038 | ||
| 2019-12-31 | Simtob Richard Isaac Director | Grant or award | +3,851 | 55,939 | ||
| 2019-12-23 | Berg Jeffrey Alan 10% owner | Sale | −200 | $2.45 | $490 | 421,100 |
| 2019-12-20 | ELLIN ROBERT S 10% owner | Purchase | +100 | $2.77 | $277 | 157,171 |
| 2019-12-20 | ELLIN ROBERT S 10% owner | Purchase | +300 | $2.83 | $850 | 199,494 |
| 2019-12-20 | Berg Jeffrey Alan 10% owner | Sale | −1,700 | $2.72 | $5K | 421,300 |
| 2019-12-19 | Wolff Allen Interim CEO | Shares withheld for taxes | −242 | $2.73 | $661 | 56,701 |
| 2019-12-19 | Gurrola Sandra M SVP of Finance | Shares withheld for taxes | −94 | $2.73 | $257 | 9,038 |
| 2019-12-19 | ELLIN ROBERT S 10% owner | Purchase | +299 | $2.72 | $814 | 199,294 |
Page 10 of 33 · 657 trades